Neoantigen-Specific TCR-Transgenic Cell Therapy against Gliomas in Mice – Genetic Engineering & Biotechnology News

Researchers from the German Cancer Research Center (DKFZ) and from Heidelberg Universitys Medical Faculty Mannheim report they have tested a neoantigen-specific transgenic immune cell therapy for malignant brain tumors for the first time using an experimental…

Click here to view the original article.